These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38029200)

  • 1. Unveiling the inhibition mechanism of
    Jo SH; Jeon HJ; Song WS; Lee JS; Kwon JE; Park JH; Kim YR; Kim MG; Baek JH; Kwon SY; Kim JS; Yang YH; Kim YG
    Front Microbiol; 2023; 14():1293149. PubMed ID: 38029200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial ecology between
    Kamiya S
    Biosci Microbiota Food Health; 2023; 42(4):229-235. PubMed ID: 37791342
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against
    Murphy CK; O'Donnell MM; Hegarty JW; Schulz S; Hill C; Ross RP; Rea MC; Farquhar R; Chesnel L
    World J Gastrointest Pathophysiol; 2023 Aug; 14(4):71-85. PubMed ID: 37727283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Bifidobacterium upon Clostridium difficile Growth and Toxicity When Co-cultured in Different Prebiotic Substrates.
    Valdés-Varela L; Hernández-Barranco AM; Ruas-Madiedo P; Gueimonde M
    Front Microbiol; 2016; 7():738. PubMed ID: 27242753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2'-Fucosyllactose inhibits proliferation of
    Wiese M; Schuren FHJ; Smits WK; Kuijper EJ; Ouwens A; Heerikhuisen M; Vigsnaes L; van den Broek TJ; de Boer P; Montijn RC; van der Vossen JMBM
    Front Cell Infect Microbiol; 2022; 12():991150. PubMed ID: 36389156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
    Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
    Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Wang R
    Front Microbiol; 2023; 14():1182612. PubMed ID: 37228365
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective growth-inhibitory effect of 8-hydroxyquinoline towards Clostridium difficile and Bifidobacterium longum subsp. longum in co-culture analysed by flow cytometry.
    Novakova J; Džunková M; Musilova S; Vlkova E; Kokoska L; Moya A; D'Auria G
    J Med Microbiol; 2014 Dec; 63(Pt 12):1663-1669. PubMed ID: 25298160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
    Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ
    Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation prebiotic promotes selective growth of bifidobacteria, suppressing
    Hirano R; Sakanaka M; Yoshimi K; Sugimoto N; Eguchi S; Yamauchi Y; Nara M; Maeda S; Ami Y; Gotoh A; Katayama T; Iida N; Kato T; Ohno H; Fukiya S; Yokota A; Nishimoto M; Kitaoka M; Nakai H; Kurihara S
    Gut Microbes; 2021; 13(1):1973835. PubMed ID: 34553672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effect of
    Yun B; Song M; Park DJ; Oh S
    Korean J Food Sci Anim Resour; 2017; 37(3):368-375. PubMed ID: 28747822
    [No Abstract]   [Full Text] [Related]  

  • 14. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effects of Bifidobacterial Strains Against Toxigenic
    Wei Y; Yang F; Wu Q; Gao J; Liu W; Liu C; Guo X; Suwal S; Kou Y; Zhang B; Wang Y; Zheng K; Tang R
    Front Microbiol; 2018; 9():888. PubMed ID: 29867801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota in burned patients with Clostridioides difficile infection.
    Shoaei P; Shojaei H; Siadat SD; Moshiri A; Vakili B; Yadegari S; Ataei B; Khorvash F
    Burns; 2022 Aug; 48(5):1120-1129. PubMed ID: 34924229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disordered Intestinal Microbial Communities During
    Chen Y; Lv T; Yan D; Zheng L; Zheng B; Wang J; Gu S; Li L
    Front Cell Infect Microbiol; 2022; 12():825189. PubMed ID: 35433508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model.
    Yang J; Meng L; Yang H
    Microbiol Spectr; 2022 Apr; 10(2):e0067222. PubMed ID: 35311540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanisms and safety of probiotics against toxigenic
    Liu D; Zeng L; Yan Z; Jia J; Gao J; Wei Y
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):967-975. PubMed ID: 32520637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.